Alteration of Ceruloplasmin in Patients with Malaria: a Systematic Review and Meta-analysis of Observational Studies

Overview

Journal Malar J

Publisher Biomed Central

Specialty Tropical Medicine

Date 2024 Nov 22

PMID 39574108

Authors

Kwuntida Uthaisar Kotepui

Aongart Mahittikorn

Polrat Wilairatana

Frederick Ramirez Masangkay

Manas Kotepui

Affiliations

Soon will be listed here.

Abstract

Background: The evidences of oxidative stress-related Plasmodium infection may alter the ceruloplasmin levels were inconsistent. This systematic review and meta-analysis aimed to collate and synthesize literatures on malaria and ceruloplasmin concentrations.

Methods: The systematic review has been registered with PROSPERO (CRD42023454859). Six electronic databases were systematically searched for investigated ceruloplasmin levels in malaria: ProQuest, EMBASE, MEDLINE, Ovid, PubMed, and Scopus, from their inception to August 2023. The quality of the included studies was assessed using the Joanna Briggs Institute (JBI) critical appraisal tools for cross-sectional, cohort, and case-control studies. Qualitative synthesis was undertaken to summarize findings from the included studies. For quantitative synthesis, a meta-analysis was performed using random-effects models.

Results: A total of 411 articles were retrieved, and nine studies were included in the review. The majority of included studies found significantly increased ceruloplasmin levels in malaria patients compared to uninfected controls. The meta-analysis showed a significant increase of ceruloplasmin in patients with malaria as compared to uninfected controls (P < 0.01, Hedge's g 1.18, 95% CI 0.90-1.47, I 59.19%, eight studies).

Conclusion: The systematic review and meta-analysis consistently revealed a significant rise in ceruloplasmin levels among malaria patients. Further research is essential to understand the variations in ceruloplasmin levels between different Plasmodium species and the severity of malaria in patients.

References

DerSimonian R, Laird N . Meta-analysis in clinical trials. Control Clin Trials. 1986; 7(3):177-88. DOI: 10.1016/0197-2456(86)90046-2. View

Roberts E, Schilsky M . Diagnosis and treatment of Wilson disease: an update. Hepatology. 2008; 47(6):2089-111. DOI: 10.1002/hep.22261. View

Farombi E, Shyntum Y, Emerole G . Influence of chloroquine treatment and Plasmodium falciparum malaria infection on some enzymatic and non-enzymatic antioxidant defense indices in humans. Drug Chem Toxicol. 2003; 26(1):59-71. DOI: 10.1081/dct-120017558. View

. Malaria: (still) a global health priority. EClinicalMedicine. 2021; 34:100891. PMC: 8102670. DOI: 10.1016/j.eclinm.2021.100891. View

Arenas de Larriva A, Alonso A, Norby F, Roetker N, Folsom A . Circulating ceruloplasmin, ceruloplasmin-associated genes and the incidence of venous thromboembolism in the Atherosclerosis Risk in Communities study. J Thromb Haemost. 2019; 17(5):818-826. PMC: 6494693. DOI: 10.1111/jth.14420. View

Park J, Lee D, Park K . Elevated serum copper and ceruloplasmin levels in Alzheimer's disease. Asia Pac Psychiatry. 2013; 6(1):38-45. DOI: 10.1111/appy.12077. View

Yeo T, Lampah D, Tjitra E, Piera K, Gitawati R, Kenangalem E . Greater endothelial activation, Weibel-Palade body release and host inflammatory response to Plasmodium vivax, compared with Plasmodium falciparum: a prospective study in Papua, Indonesia. J Infect Dis. 2010; 202(1):109-12. PMC: 4313368. DOI: 10.1086/653211. View

Siddiqi U, Begum S, Shahjadi S, Afroz S, Mahruba S, Parvin J . Plasma zinc, copper and serum ceruloplasmin levels of autism spectrum disorder children in Bangladesh. Heliyon. 2023; 9(8):e18624. PMC: 10448426. DOI: 10.1016/j.heliyon.2023.e18624. View

Karaye K, Yahaya I, Lindmark K, Henein M . Serum selenium and ceruloplasmin in nigerians with peripartum cardiomyopathy. Int J Mol Sci. 2015; 16(4):7644-54. PMC: 4425040. DOI: 10.3390/ijms16047644. View

10.

Dzeing-Ella A, Nze Obiang P, Tchoua R, Planche T, Mboza B, Mbounja M . Severe falciparum malaria in Gabonese children: clinical and laboratory features. Malar J. 2005; 4:1. PMC: 546207. DOI: 10.1186/1475-2875-4-1. View

11.

Erel O, Kocyigit A, Avci S, Aktepe N, Bulut V . Oxidative stress and antioxidative status of plasma and erythrocytes in patients with vivax malaria. Clin Biochem. 1998; 30(8):631-9. DOI: 10.1016/s0009-9120(97)00119-7. View

12.

Satyanarayana G, Keisham N, Batra H, V S, Khan M, Gupta S . Evaluation of Serum Ceruloplasmin Levels as a Biomarker for Oxidative Stress in Patients With Diabetic Retinopathy. Cureus. 2021; 13(2):e13070. PMC: 7932825. DOI: 10.7759/cureus.13070. View

13.

Seyrek A, Kocyigit A, Erel O . Essential trace elements selenium, zinc, copper, and iron concentrations and their related acute-phase proteins in patients with vivax malaria. Biol Trace Elem Res. 2005; 106(2):107-15. DOI: 10.1385/BTER:106:2:107. View

14.

Dadu R, Dodge R, Nambi V, Virani S, Hoogeveen R, Smith N . Ceruloplasmin and heart failure in the Atherosclerosis Risk in Communities study. Circ Heart Fail. 2013; 6(5):936-43. PMC: 3908901. DOI: 10.1161/CIRCHEARTFAILURE.113.000270. View

15.

Fox P, Mukhopadhyay C, Ehrenwald E . Structure, oxidant activity, and cardiovascular mechanisms of human ceruloplasmin. Life Sci. 1995; 56(21):1749-58. DOI: 10.1016/0024-3205(95)00146-w. View

16.

Popa G, Popa M . Recent Advances in Understanding the Inflammatory Response in Malaria: A Review of the Dual Role of Cytokines. J Immunol Res. 2021; 2021:7785180. PMC: 8592744. DOI: 10.1155/2021/7785180. View

17.

Atanasiu R, Stea D, Mateescu M, Vergely C, Dalloz F, Briot F . Direct evidence of caeruloplasmin antioxidant properties. Mol Cell Biochem. 1999; 189(1-2):127-35. DOI: 10.1023/a:1006945713860. View

18.

Page M, McKenzie J, Bossuyt P, Boutron I, Hoffmann T, Mulrow C . The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021; 372:n71. PMC: 8005924. DOI: 10.1136/bmj.n71. View

19.

Goncalves R, Scopel K, Bastos M, Ferreira M . Cytokine balance in human malaria: does Plasmodium vivax elicit more inflammatory responses than Plasmodium falciparum?. PLoS One. 2012; 7(9):e44394. PMC: 3433413. DOI: 10.1371/journal.pone.0044394. View

20.

Hemmer C, Holst F, Kern P, Chiwakata C, Dietrich M, Reisinger E . Stronger host response per parasitized erythrocyte in Plasmodium vivax or ovale than in Plasmodium falciparum malaria. Trop Med Int Health. 2006; 11(6):817-23. DOI: 10.1111/j.1365-3156.2006.01635.x. View